文献速递肝胆胰外科围术期管理与 ERAS

微创全胰腺切除联合自体胰岛移植治疗慢性胰腺炎:机器人入路

Minimally invasive total pancreatectomy with islet autotransplantation for chronic pancreatitis: the robotic approach.
PubMed 文献 · Surg Endosc · 2024-06-06

该研究比较了2013至2021年间61例成人全胰腺切除联合自体胰岛移植(TPIAT)患者中机器人、腹腔镜与开腹三种入路的手术与胰岛特征、术后并发症及1年血糖结局。机器人TPIAT较开腹手术失血量更少、住院时间更短,在可行性、安全性、疼痛控制和1年血糖结局方面与开腹手术相似。作者认为机器人技术有望成为经验丰富胰腺外科医生的首选手术入路。

要点

  • 机器人TPIAT较开腹TPIAT失血量减少(324 vs 843 mL,p=0.004),住院时间缩短(8.6 vs 12.6天,p=0.017)。
  • 机器人TPIAT与开腹TPIAT在手术时间、30天再入院率、90天并发症率及1年血糖结局方面无显著差异。
  • 微创TPIAT(机器人及腹腔镜)较开腹TPIAT重症监护室住院时间更短(2.9 vs 4.5天,p=0.002),1年死亡率为0%。

核心结论

  • 机器人TPIAT较开腹TPIAT住院时间缩短33%(获益4天),在可行性、安全性、疼痛控制和1年血糖结局方面与开腹TPIAT相似。
  • 作者认为机器人技术作为TPIAT多学科治疗的新组成部分,有望发展成为经验丰富胰腺外科医生的主要手术入路。

研究设计与样本

  • 2013年至2021年间,61例成人患者在全面评估后接受TPIAT(97%为慢性胰腺炎),术中在本地进行胰岛分离。
  • 研究比较了机器人TPIAT、腹腔镜TPIAT与开腹TPIAT的术中手术与胰岛特征、术后并发症与死亡率及1年血糖结局。

主要发现

  • 微创TPIAT共41例(67%,其中机器人15例、腹腔镜26例),平均重症监护室住院时间较开腹TPIAT更短(2.9 vs 4.5天,p=0.002)。
  • 机器人TPIAT自2017年起取代腹腔镜TPIAT成为首选微创入路,其失血量较开腹TPIAT减少(324 vs 843 mL,p=0.004),手术时间(609 vs 562分钟)、30天再入院率(7% vs 15%)和90天并发症率(13% vs 20%)相似。
  • 机器人TPIAT与开腹TPIAT的1年C肽检出率(73% vs 88%)和1年胰岛素依赖率(75% vs 92%)无差异。
  • 机器人TPIAT平均住院时间为8.6天,短于腹腔镜TPIAT(11.5天,p=0.031)和开腹TPIAT(12.6天,p=0.017)。
  • 两种微创入路的1年死亡率均为0%。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

INTRODUCTION: Total pancreatectomy with islet autotransplantation (TPIAT) treats refractory pain in chronic pancreatitis, prevents episodes of acute exacerbation, and mitigates postoperative brittle diabetes. The minimally invasive (MIS) approach offers a decreased surgical access trauma and enhanced recovery. Having established a laparoscopic TPIAT program, we adopted a robotic approach (R-TPIAT) and studied patient outcomes compared to open TPIAT. METHODS: Between 2013 and 2021, 61 adult patients underwent TPIAT after a comprehensive evaluation (97% chronic pancreatitis). Pancreatic islets were isolated on-site during the procedure. We analyzed and compared intraoperative surgical and islet characteristics, postoperative morbidity and mortality, and 1-year glycemic outcomes. RESULTS: MIS-TPIAT was performed in 41 patients (67%, 15 robotic and 26 laparoscopic), and was associated with a shorter mean length of intensive care unit stay compared to open TPIAT (2.9 vs 4.5 days, p = 0.002). R-TPIAT replaced laparoscopic TPIAT in 2017 as the MIS approach of choice and demonstrated decreased blood loss compared to open TPIAT (324 vs 843 mL, p = 0.004), similar operative time (609 vs 562 min), 30-day readmission rate (7% vs 15%), and 90-day complication rate (13% vs 20%). The glycemic outcomes including C-peptide detection at 1-year (73% vs 88%) and insulin dependence at 1-year (75% vs 92%) did not differ. The mean length of hospital stay after R-TPIAT was 8.6 days, shorter than for laparoscopic (11.5 days, p = 0.031) and open TPIAT (12.6 days, p = 0.017). Both MIS approaches had a 1-year mortality rate of 0%. CONCLUSIONS: R-TPIAT was associated with a 33% reduction in length of hospital stay (4-day benefit) compared to open TPIAT. R-TPIAT was similar to open TPIAT on measures of feasibility, safety, pain control, and 1-year glycemic outcomes. Our data suggest that robotic technology, a new component in the multidisciplinary therapy of TPIAT, is poised to develop into the primary surgical approach for experienced pancreatic surgeons.

来源:Surg Endosc,查看原文。版权归原作者所有。

引用

  1. Kinny-Köster B, Walsh CM, Sun Z, et al. Minimally invasive total pancreatectomy with islet autotransplantation for chronic pancreatitis: the robotic approach. Surg Endosc. 2024. PMID: 38844730. doi:10.1007/s00464-024-10904-w

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。